CORDIS Project
Funding breakdown and partner intelligence are Premium
Sign in and upgrade to Premium for EU contribution totals, consortium analytics, OpenAlex research context, and AI summaries. · 0 consortium intelligence fields visible of 1
Start free • Cancel anytime • 14-day refund guarantee
This project conducts a clinical trial to evaluate the effectiveness of PDGF-BB as a regenerative therapy for Parkinson’s Disease. By promoting brain repair mechanisms, it aims to provide a disease-modifying treatment that could significantly improve patient outcomes.
The goal of this project is to perform a European phase II clinical trial to demonstrate that PDGF-BB acts as a unique regenerative therapy for Parkinson’s Disease (PD), aimed at reversing the course of the disease, by promotion of endogenous brain repair mechanisms.
Current pharmacological therapies for PD carry side-effects and become less effective as the disease progresses.
This causes immense suffering for patients in their daily lives.
There is currently no established disease-modifying,…
NEWRON SWEDEN AB
Partner organizations (coordinator is shown above), with normalized type and CORDIS activity type. Guests see up to 4 partners.
Sweden, LUND
Type: University / higher education
Activity type: Higher or Secondary Education Establishments
SME: No
United Kingdom, LONDON
Type: Company (for-profit)
Activity type: Private for-profit entities (excluding Higher or Secondary Education Establishments)
Austria, vienna
Type: Public body
Activity type: Public bodies (excluding Research Organisations and Secondary or Higher Education Establishments)
Similar projects, consortium collaboration history, frequent partners, and OpenAlex research context.
Guests see up to 5 EuroSciVoc fields.
Guests see up to 5 topics.
Guests see up to 5 sectors.
